A study on measurement of KP-607 concentrations in nails (Phase I) Investigation on KP-607 concentrations in nails when applied repeatedly to toenails in patients with onychomycosis.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080224040

Enrollment

Registered

2018-09-06

Start date

2018-09-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Onychomycosis

Interventions

investigational material(s) Generic name etc : 5% KP-607 INN of investigational material : None Therapeutic category code : 265 Anti-dermoinfectives Dosage and Administration for Investigational mater

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Japanese subjects The subjects diagnosed with onychomycosis

Exclusion criteria

Exclusion criteria: Patients who have received corticosteroids or immunosuppressants within a certain period of time before screening period.

Design outcomes

Primary

Measure	Time frame
pharmacokinetics KP-607 concentrations in nails when applied repeatedly to toenails in patients with onychomycosis.	—

Secondary

Measure	Time frame
safety efficacy safety, efficacy	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026